Morphine-6-glucuronide: an analgesic of the future?

@article{Ltsch2001Morphine6glucuronideAA,
  title={Morphine-6-glucuronide: an analgesic of the future?},
  author={J{\"o}rn L{\"o}tsch and Gerd 7 Geisslinger},
  journal={Clinical pharmacokinetics},
  year={2001},
  volume={40 7},
  pages={485-99}
}
Morphine-6-beta-glucuronide (M6G) is an opioid agonist that plays a role in the clinical effects of morphine. Although M6G probably crosses the blood-brain barrier with difficulty, during long term morphine administration it may reach sufficiently high CNS concentrations to exert clinically relevant opioid effects. As a consequence of its almost exclusive renal elimination, M6G may accumulate in the body of patients with impaired renal function and cause severe opioid adverse effects with… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 33 extracted citations

Contribution of UDP-glucuronosyltransferase 1A1 and 1A8 to morphine-6-glucuronidation and its kinetic properties.

Drug metabolism and disposition: the biological fate of chemicals • 2008
View 2 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…